SynAct Pharma AB (SYNACT) — Cash Flow Reinvestment Rate
Latest as of June 2019:
0.22x
SynAct Pharma AB (SYNACT) has a Cash Flow Reinvestment Rate of 0.22x as of June 2019, reinvesting Skr394.90K (capex Skr394.90K ) from operating cash flow of Skr1.77 Million. Explore SynAct Pharma AB operating cash flow efficiency to assess how effectively this company generates cash.
Reinvestment Rate
0.22x
(Capex + Investments) / Operating CF
Total Reinvested
Skr394.90K
Capex + Investments
Operating Cash Flow
Skr1.77 Million
SEK
Capital Expenditures
Skr394.90K
SEK
Annual Cash Flow Reinvestment Rate for SynAct Pharma AB (None–None)
Year-by-year capital reinvestment analysis for SynAct Pharma AB. For live market cap and broader valuation context, see market value of SynAct Pharma AB.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow